Plasminogen activators potentiate thrombin-induced brain injury - PubMed (original) (raw)
. 1998 Jun;29(6):1202-7; discussion 1208.
doi: 10.1161/01.str.29.6.1202.
Affiliations
- PMID: 9626295
- DOI: 10.1161/01.str.29.6.1202
Plasminogen activators potentiate thrombin-induced brain injury
B E Figueroa et al. Stroke. 1998 Jun.
Abstract
Background and purpose: Evidence suggests that cerebral edema following intracerebral hemorrhage (i.c.h.) results from a mass effect in combination with neurotoxic injury from clot-derived substrates such as thrombin. Thrombolytics can compete for thrombin inhibitors endogenous to the brain. This study examines the effect of intracerebral infusion of thrombolytics, tissue plasminogen activator (tPA), and urokinase (uPA), individually and in combination with thrombin.
Methods: Various 100 microL solutions were stereotactically infused into the right basal ganglia of adult male rats. Animals were euthanized 24 hours later, and brain sections were taken for measurement of water, sodium, and potassium content.
Results: Regardless of dose, when infused independently tPA (2 micrograms) and uPA (2000 and 5000 Plough units) failed to produce any significant tissue edema compared with vehicle control tissues. However, when either thrombolytic was infused concomitantly with thrombin (1 or 5 U), brain water, sodium, and potassium content all demonstrated a potentiation of thrombin-induced brain injury (P < 0.05). In addition, animal deaths were significantly greater than expected in animals receiving a combination of tPA (2 micrograms) and thrombin (5 U) compared with either drug alone (P < 0.001).
Conclusions: This study indicates that brain edema caused by thrombin can be greatly amplified by the presence of plasminogen activators, perhaps because the latter compete for naturally occurring thrombin inhibitors. In the context of ICH, our results suggest that the use of tPA or uPA to lyse clotted blood in brain parenchyma may promote edema formation in surrounding tissue.
Similar articles
- Concomitant intracerebral infusion of tissue plasminogen activator and thrombin leads to brain injury.
O'Lynnger T, He Y, Hu H, Hua Y, Muraszko KM, Xi G. O'Lynnger T, et al. Acta Neurochir Suppl. 2008;105:55-8. doi: 10.1007/978-3-211-09469-3_12. Acta Neurochir Suppl. 2008. PMID: 19066083 - Role of blood clot formation on early edema development after experimental intracerebral hemorrhage.
Xi G, Wagner KR, Keep RF, Hua Y, de Courten-Myers GM, Broderick JP, Brott TG, Hoff JT. Xi G, et al. Stroke. 1998 Dec;29(12):2580-6. doi: 10.1161/01.str.29.12.2580. Stroke. 1998. PMID: 9836771 - Activation of p44/42 mitogen activated protein kinases in thrombin-induced brain tolerance.
Xi G, Hua Y, Keep RF, Duong HK, Hoff JT. Xi G, et al. Brain Res. 2001 Mar 23;895(1-2):153-9. doi: 10.1016/s0006-8993(01)02064-9. Brain Res. 2001. PMID: 11259772 - Edema from intracerebral hemorrhage: the role of thrombin.
Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Lee KR, et al. J Neurosurg. 1996 Jan;84(1):91-6. doi: 10.3171/jns.1996.84.1.0091. J Neurosurg. 1996. PMID: 8613842 - Pathophysiology of brain edema formation.
Xi G, Keep RF, Hoff JT. Xi G, et al. Neurosurg Clin N Am. 2002 Jul;13(3):371-83. doi: 10.1016/s1042-3680(02)00007-4. Neurosurg Clin N Am. 2002. PMID: 12486926 Review.
Cited by
- Reduced vascular endothelial growth factor expression in contusive spinal cord injury.
Herrera JJ, Nesic O, Narayana PA. Herrera JJ, et al. J Neurotrauma. 2009 Jul;26(7):995-1003. doi: 10.1089/neu.2008.0779. J Neurotrauma. 2009. PMID: 19257807 Free PMC article. - Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema.
Carhuapoma JR, Barrett RJ, Keyl PM, Hanley DF, Johnson RR. Carhuapoma JR, et al. Neurocrit Care. 2008;8(3):322-9. doi: 10.1007/s12028-008-9074-y. Neurocrit Care. 2008. PMID: 18327659 Free PMC article. Clinical Trial. - Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage.
Wang J, Tsirka SE. Wang J, et al. Neurocrit Care. 2005;3(1):77-85. doi: 10.1385/NCC:3:1:077. Neurocrit Care. 2005. PMID: 16159103 Review. - Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice.
Xue M, Hollenberg MD, Yong VW. Xue M, et al. J Neurosci. 2006 Oct 4;26(40):10281-91. doi: 10.1523/JNEUROSCI.2806-06.2006. J Neurosci. 2006. PMID: 17021183 Free PMC article. - Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs.
Zhang J, Groff RF 4th, Chen XH, Browne KD, Huang J, Schwartz ED, Meaney DF, Johnson VE, Stein SC, Rojkjaer R, Smith DH. Zhang J, et al. Exp Neurol. 2008 Apr;210(2):645-55. doi: 10.1016/j.expneurol.2007.12.019. Epub 2008 Jan 5. Exp Neurol. 2008. PMID: 18291370 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous